Suppr超能文献

通过将去甲肾上腺素与外周的哌唑嗪结合到外侧臂旁核中来促进钠摄入。

Facilitation of sodium intake by combining noradrenaline into the lateral parabrachial nucleus with prazosin peripherally.

机构信息

Department of Physiology and Pathology, School of Dentistry, São Paulo State University, UNESP, Araraquara, São Paulo, Brazil.

出版信息

Pharmacol Biochem Behav. 2013 Oct;111:111-9. doi: 10.1016/j.pbb.2013.08.017. Epub 2013 Sep 13.

Abstract

Injections of noradrenaline into the lateral parabrachial nucleus (LPBN) increase arterial pressure and 1.8% NaCl intake and decrease water intake in rats treated with the diuretic furosemide (FURO) combined with a low dose of the angiotensin converting enzyme inhibitor captopril (CAP). In the present study, we investigated the influence of the pressor response elicited by noradrenaline injected into the LPBN on FURO+CAP-induced water and 1.8% NaCl intake. Male Holtzman rats with bilateral stainless steel guide-cannulas implanted into LPBN were used. Bilateral injections of noradrenaline (40 nmol/0.2 μl) into the LPBN increased FURO+CAP-induced 1.8% NaCl intake (12.2±3.5, vs., saline: 4.2±0.8 ml/180 min), reduced water intake and strongly increased arterial pressure (50±7, vs. saline: 1±1 mmHg). The blockade of the α1 adrenoceptors with the prazosin injected intraperitoneally abolished the pressor response and increased 1.8% NaCl and water intake in rats treated with FURO+CAP combined with noradrenaline injected into the LPBN. The deactivation of baro and perhaps volume receptors due to the cardiovascular effects of prazosin is a mechanism that may facilitate water and NaCl intake in rats treated with FURO+CAP combined with noradrenaline injected into the LPBN. Therefore, the activation of α2 adrenoceptors with noradrenaline injected into the LPBN, at least in dose tested, may not completely remove the inhibitory signals produced by the activation of the cardiovascular receptors, particularly the signals that result from the extra activation of these receptors with the increase of arterial pressure.

摘要

向外侧臂旁核 (LPBN) 内注射去甲肾上腺素会增加动脉血压,并增加接受利尿剂呋塞米 (FURO) 和低剂量血管紧张素转换酶抑制剂卡托普利 (CAP) 联合治疗的大鼠的 1.8%NaCl 摄入量,并减少水摄入量。在本研究中,我们研究了 LPBN 内注射去甲肾上腺素引起的升压反应对 FURO+CAP 诱导的水和 1.8%NaCl 摄入的影响。使用双侧植入 LPBN 不锈钢引导套管的雄性霍尔茨曼大鼠。双侧 LPBN 内注射去甲肾上腺素 (40 nmol/0.2 μl) 会增加 FURO+CAP 诱导的 1.8%NaCl 摄入量 (12.2±3.5,vs. 生理盐水:4.2±0.8 ml/180 min),减少水摄入量并强烈增加动脉血压 (50±7,vs. 生理盐水:1±1 mmHg)。腹腔内注射哌唑嗪阻断 α1 肾上腺素受体可消除升压反应,并增加 FURO+CAP 联合 LPBN 内注射去甲肾上腺素治疗大鼠的 1.8%NaCl 和水摄入量。由于哌唑嗪对心血管的影响,压力和容量感受器失活可能是促进 FURO+CAP 联合 LPBN 内注射去甲肾上腺素治疗大鼠水和 NaCl 摄入的机制。因此,至少在测试剂量下,LPBN 内注射去甲肾上腺素激活 α2 肾上腺素受体可能不会完全消除心血管受体激活产生的抑制信号,特别是由于这些受体的额外激活而导致的信号动脉血压升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验